Apatinib Combined With SHR-1210 Injection in the Treatment of Patients With Removable IB-IIIA NSCLC

NCT04133337 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Lung Diseases
Neoplasms
Respiratory Tract Diseases
Thoracic Neoplasms
Non-small-cell Lung Cancer

Interventions

DRUG: Apatinib
DRUG: SHR-1210

Sponsor

Sichuan Cancer Hospital and Research Institute

Collaborators

[object Object]